Roela Kolici-Sadushi

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension.

Prognostic Value of Acute Vasoreactivity in Chronic Thromboembolic Pulmonary Hypertension.

Journal: Pulmonary circulation
Published: October 08, 2025

Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease.

Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease.

Journal: Pulmonary circulation
Published: September 03, 2025

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

Long-term effects of medical treatment in patients with chronic thromboembolic pulmonary hypertension.

Journal: ERJ open research
Published: June 06, 2025

Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension).

Long-Term Treatment With Subcutaneous Treprostinil in Patients With Severe Inoperable Chronic Thromboembolic Pulmonary Hypertension in the Multimodal Therapy Era (Data From CTREPH Study Open Label Extension).

Journal: Pulmonary circulation
Published: January 02, 2025

Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.

Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy.

Journal: Circulation
Published: September 17, 2024

Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.

Asymmetric Dimethylarginine and NT-proBNP Levels Provide Synergistic Information in Pulmonary Arterial Hypertension.

Journal: JACC. Heart failure
Published: July 10, 2023

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.

Journal: Pulmonary circulation
Published: May 01, 2023

Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact.

Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact.

Journal: Vascular pharmacology
Published: June 19, 2022

Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension.

Efficacy and Safety of Percutaneous Pulmonary Artery Subtotal Occlusion and Chronic Total Occlusion Intervention in Chronic Thromboembolic Pulmonary Hypertension.

Journal: Circulation. Cardiovascular interventions
Published: July 16, 2021

Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension.

Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension.

Journal: Clinics in chest medicine
Published: February 05, 2021

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry.

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry.

Journal: ERJ open research
Published: November 13, 2020

Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension.

Treprostinil for the treatment of chronic thromboembolic pulmonary hypertension.

Journal: Expert review of respiratory medicine
Published: September 24, 2019
Showing 1-12 of 22

Last Updated: 09/26/2026